Enterprise Financial Services Corp Catalent, Inc. Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $903 - $1,041	-9 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $772 - $948	9 New	9 $1,000
Q4 2018 Jan 25, 2019	SELL	$29.95 - $46.34 $2,485 - $3,846	-83 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$40.12 - $45.55 $3,329 - $3,780	83 New	83 $4,000

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.